Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

Clinical trial NCT00923234 · TERMINATED

Trial details

NCT number: NCT00923234
Sponsor: Technische Universität Dresden
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myelogenous Leukemia

Start date: 2009-06-01
Primary completion: 2012-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.